Related references
Note: Only part of the references are listed.Multifunctional intracellular matrix metalloproteinases: implications in disease
Wesam Bassiouni et al.
FEBS JOURNAL (2021)
Lip and Oral Cavity Squamous Cell Carcinoma
Adam Howard et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer
Andreas Jonsson et al.
JOURNAL OF SURGICAL RESEARCH (2021)
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics
Ambika Chamoli et al.
ORAL ONCOLOGY (2021)
Estimation of serum and salivary matrix metalloproteinase levels in oral squamous cell carcinoma patients: a systematic review and meta-analysis
Farzad Rezaei et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2021)
Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer
Ya-Ting Chang et al.
CANCERS (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes
Amy Anne D. Lassig et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer
Ho Jung An et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
The Significance of Matrix Metalloproteinases in Oral Diseases
Mateusz Maciejczyk et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
MMP Inhibitors: Past, present and future
Jillian M. Cathcart et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma
Rui Yang et al.
ONCOTARGETS AND THERAPY (2013)
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
Laszlo Herszenyi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Overexpression of MMP-1 and VEGF-C is Associated with a Less Favorable Prognosis in Esophageal Squamous Cell Carcinoma
Yi-Sheng Tao et al.
ONKOLOGIE (2012)
MMP-1 expression has an independent prognostic value in breast cancer
Pia Bostrom et al.
BMC CANCER (2011)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Jayawant N. Mandrekar
JOURNAL OF THORACIC ONCOLOGY (2010)
Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients
Min Li et al.
LUNG CANCER (2010)
Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers
Ching-Yu Yen et al.
BIOMARKERS (2009)
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies
Daniel Buergy et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Matrix metalloproteinase (MMP)-1,-9 and-13 as prognostic factors in salivary gland cancer
Heikki Luukkaa et al.
ACTA OTO-LARYNGOLOGICA (2008)
Prognostic significance of matrix metalloproteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer
Marja Hilska et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Clinical significance of MMP-2 and MMP-9 in patients with oral cancer
Beena P. Patel et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis
I Poola et al.
NATURE MEDICINE (2005)
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent
V Gouyer et al.
CANCER (2005)
MMP-1: the elder of the family
A Pardo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Share Paper
